"Bolus" methylprednisolone versus ACTH in the treatment of multiple sclerosis
- PMID: 6311774
- DOI: 10.1007/BF02043900
"Bolus" methylprednisolone versus ACTH in the treatment of multiple sclerosis
Abstract
Two groups of 30 multiple sclerosis (MS) patients were randomly treated with corticotrophin (ACTH) and "bolus" 6-methylprednisolone (B/6-MP) to compare the effectiveness of the two treatments. Both ACTH and B/6-MP showed a similar effect, improving acute neurological deficits of MS patients without modifying the long term course of the disease. B/6-MP, showing prompt effectiveness and lack of side effects, may be regarded as a useful alternative to conventional treatment of MS.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical